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Presentation notes
Slide 1: Science Signaling logo
The slideshow and notes for this presen-
tation are provided by Science Signaling 
(www.sciencesignaling.org).
Slide 2: Roles of GRK2 in cell signal-
ing beyond GPCR desensitization: GRK2-
HDAC6 interaction modulates cell spreading 
and motility
This talk briefly reviews cellular functions 
of G protein–coupled receptor 2 (GRK2) be-
yond its canonical role in G protein–coupled 
receptor (GPCR) desensitization and focus-
es on the description of a recently identified 
GRK2-HDAC6 interaction that modulates 
epithelial cell spreading and motility.
Slide 3: GRKs and arrestins are nega-
tive regulators of GPCR signaling
G protein–coupled receptor kinases (GRKs) 
were initially identified as serine-threonine 
kinases that are able to phosphorylate ago-
nist-activated GPCRs, triggering the bind-
ing of arrestins to the receptor, which im-
pairs G protein coupling in a process known 
as desensitization (1). Conformational 
changes in receptor-bound arrestins also fa-
cilitate their interaction with components of 
the endocytic machinery, leading to recep-
tor internalization (2).
Slide 4: GRKs and arrestins regulate 
GPCR signaling and participate in signal 
propagation
In addition to this canonical, inhibitory role 
in GPCR signaling, several laboratories 
have shown that arrestins can act as scaf-
folding molecules that bring different sig-
naling molecules into the receptor complex, 
including the tyrosine kinase c-Src, the ade-
nosine 3′,5′-monophosphate (cAMP) phos-
phodiesterase PDE4, the cytoskeletal regu-
lator Ral-GDS, the ubiquitin ligase Mdm2, 
and components of the nuclear factor–κB 
(NF-κB) and mitogen-activated protein ki-
nase (MAPK) signaling pathways (1, 3). 
The signalosomes orchestrated by arrestins 
would allow signal propagation at defined 
locations, contributing to the overall cellu-
lar response to the presence of an agonist.
It should be stressed, however, that the 
cellular role of GRKs is not limited to pro-
moting β-arrestin binding to activated GP-
CRs. GRKs are multidomain proteins with 
diverse cellular functions, the expression 
and function of which are tightly regulated 
and altered in several cardiovascular, inflam-
matory, and tumor pathologies, thus sug-
gesting that these changes may contribute to 
the onset or development of disease (4).
Slide 5: GRK2 is a key node in signal 
transduction pathways: The complex GRK2 
interactome
GRK2, an ubiquitous and essential member 
of the GRK family, is emerging as a key, in-
tegrative node in many signaling networks 
because it has an extensive repertoire of 
functional interactions (its interactome). 
Besides phosphorylating activated GPCRs, 
GRK2 is functionally related to several 
members of the receptor tyrosine kinase 
family, phosphorylates a variety of nonre-
ceptor substrates, and dynamically interacts 
with other important signal transduction 
partners in a manner that is independent 
of its kinase activity (4, 5). For instance, 
as emphasized in this slide, in the past few 
years our group has reported GRK2 inter-
actions with the mitogen-activated or ex-
tracellular signal–regulated protein kinase 
kinase MEK (6), the MAPK p38 (7), the 
ARF (adenosine diphosphate ribosylation 
factor) GTPase (guanosine triphosphatase)-
activating protein GIT1 (8), Mdm2 (9), the 
prolyl-isomerase Pin1 (10), and insulin 
receptor substrate 1 (IRS1) (11). Some of 
these interactions underlie the participation 
of GRK2 in basic cellular processes such as 
cell cycle progression (10), cell migration 
(8), and insulin resistance (11).
Slide 6: Questions arising from the 
complexity of the GRK2 interactome
In the face of such a complex interactome, 
research in this field is aimed at addressing 
the following questions: How are the differ-
ent networks of potential GRK2 functional 
interactions orchestrated in a stimulus-, con-
text-, or cell type–specific manner? Which 
is the relevant GRK2 interactome in a given 
cell type and physiological situation? What 
are the physiological and pathological im-
plications of altered GRK2 abundance or 
activity?
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g protein–coupled receptor kinase 2 (grK2) is a ubiquitous, essential protein ki-
nase that is emerging as an integrative node in many signaling networks. Moreover, 
changes in grK2 abundance and activity have been identified in several inflamma-
tory, cardiovascular disease, and tumor contexts, suggesting that those alterations 
may contribute to the initiation or development of pathologies. grKs were initially 
identified as key players in the desensitization and internalization of multiple g pro-
tein–coupled receptors (gPcrs), but grK2 also phosphorylates several non-gPcr 
substrates and dynamically associates with a variety of proteins related to signal 
transduction. ongoing research in our laboratory is aimed at understanding how 
specific grK2 interactomes are orchestrated in a stimulus-, context-, or cell type–
specific manner. We have recently identified an interaction between grK2 and his-
tone deacetylase 6 (HDac6) that modulates cell spreading and motility. HDac6 is a 
major cytoplasmic a-tubulin deacetylase that is involved in cell motility and adhe-
sion. grK2 dynamically and directly associates with and phosphorylates HDac6 to 
stimulate its a-tubulin deacetylase activity at specific cellular localizations such as 
the leading edge of migrating cells, thus promoting local tubulin deacetylation and 
enhanced motility. grK2-HDac6–mediated regulation of tubulin acetylation also 
modulates cellular spreading. this grK2-HDac6 functional interaction may have 
important implications in pathological contexts related to epithelial cell migration.
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Slide 7: Examples of relevant GRK2 
interactomes reported in given cell types 
and physiological settings
Recent research by different laboratories (4, 
12) has started to define the distinct relevant 
functional interactions of GRK2—both re-
lated and unrelated to its canonical role as 
GPCR modulator—underlying its partici-
pation in physiological or pathological pro-
cesses in different cell types. For example, 
in lymphocytes GRK2 interacts with chemo-
kine receptors and modulates the interaction 
between MEK and ERK (extracellular signal-
regulated kinase) and the status of p38 acti-
vation, so the decreased GRK2 abundance 
reported in inflammatory contexts would pro-
mote enhanced signaling through these path-
ways. On the other hand, in adipocytes GRK2 
can act as an inhibitor of insulin-mediated 
signaling by interacting with Gq and G11 (13) 
or by forming dynamic complexes with IRS1, 
which is consistent with a role for GRK2 in 
insulin resistance and obesity (11).
Slide 8: GRK2 interactome in epithelial 
cell migration
Our group is actively investigating the role 
of GRK2 in epithelial cell migration and has 
recently unveiled a previously undocumented 
GRK2-HDAC6 interaction that modulates 
cell spreading and motility (14). In epithelial 
cells, locomotion is initiated by chemoattrac-
tants acting through either GPCR or tyrosine 
kinase receptors that trigger downstream sig-
nals leading to cell polarization, projection 
of cytoplasmic extensions (pseudopodia or 
lamellipodia) that are enriched in actin and 
devoid of organelles at the leading edge, and 
cell body translocation forward by modula-
tion of the actin cytoskeleton and microtubule 
(MT) dynamics (15). Acetylation and deacet-
ylation of the MT component α-tubulin has 
been suggested to play a prominent role in 
cell migration and adhesion (16).
Slide 9: HDAC6 is a cytoplasmic 
deacetylase
HDAC6 is a class IIa cytoplasmic histone 
deacetylase that can deacetylate substrates 
such as α-tubulin, cortactin, and Hsp90 to 
modulate diverse cellular processes such as 
agressome or stress granule (SG) formation, 
cell spreading, and migration. In particular, 
HDAC6 up-regulation and concomitant de-
creased tubulin acetylation enhance the mo-
tility of different cell types including fibro-
blasts (17) and breast cancer cells (18, 19).
Slide 10: GRK2 positively regulates 
epithelial cell migration
We have recently shown that GRK2 posi-
tively regulates integrin-dependent motility 
in epithelial cells and fibroblasts (8). This 
effect was due in part to GRK2’s kinase 
activity–independent modulation of the 
scaffold function of GIT-1 in the context of 
Rac-PAK-MEK-ERK1/2 pathway activa-
tion, thus promoting F-actin remodeling at 
the cell periphery and focal adhesion turn-
over. However, we also noted that increased 
GRK2 abundance enhanced cell migration 
on fibronectin (FN) in a way that required 
the kinase activity of GRK2. Whereas in-
creased abundance of wild-type (WT) 
GRK2 enhanced migration of HeLa cells 
in a wound-healing assay, wound closure 
was blocked by expression of a catalytically 
inactive point mutant (GRK2K220R) or upon 
GRK2 deletion in mouse embryonic fibro-
blasts (MEFs) by using a Cre-Lox system 
(left).
Slide 11: GRK2 abundance modu-
lates the extent of tubulin acetylation in a 
kinase-activity dependent manner
Are GRK2 and HDAC6 functionally related 
in this positive modulation of epithelial cell 
migration? Interestingly, GRK2 down-reg-
ulation in MEFs derived from hemizygous 
GRK2+/− mice clearly showed enhanced tu-
bulin acetylation as compared with that of 
WT MEFs, without apparent changes in 
the expression of either HDAC6 or SIRT2 
deacetylases (top left). Similarly, deletion 
of GRK2 in MEFs by using a Cre-Lox sys-
tem (bottom left) or GRK2 down-regulation 
triggered by means of RNA interference in 
HeLa cells (middle) led to increased accu-
mulation of acetylated tubulin in parallel 
with reduced motility. Notably, acetylated 
tubulin markedly accumulated in HeLa cells 
that stably overexpressed a transgene encod-
ing either a catalytically inactive GRK2 (K1 
cells) or a version of GRK2 bearing a muta-
tion at the S670 regulatory site (GRK2S670A; 
A1 cells) and correlated with the impaired 
ability of these cells to migrate toward both 
mechanical (wounding) and chemotactic 
cues (top right).
Slide 12: The effect of GRK2 on cell 
migration is counteracted by tubacin, a 
specific inhibitor of HDAC6-dependent 
deacetylation of tubulin.
In support of GRK2-mediated enhanced 
cell migration requiring α-tubulin acety-
lation-deacetylation cycling, the presence 
of the general HDAC inhibitor TSA or of 
tubacin—a specific inhibitor of HDAC6 tu-
bulin (but not cortactin) deacetylase activ-
ity—counteracted the ability of increased 
GRK2 abundance to stimulate cell motility. 
These data suggested that GRK2 specifi-
cally facilitates HDAC6 activity toward tu-
bulin in order to promote deacetylation and 
enhanced cell motility and posed the ques-
tion of whether this was a result of a direct 
or indirect interaction between GRK2 and 
HDAC6.
Slide 13: HDAC6 and GRK2 colocal-
ize in the leading edge of migrating cells, 
coincident with decreased local tubulin 
acetylation
Both GRK2 and HDAC6 are recruited to 
chemoattractant-induced pseudopodia, and 
the proteins colocalized in the leading edge of 
polarized HeLa cells that were directionally 
migrating to close a scratch wound. Interest-
ingly, acetylated MTs displayed an asymmet-
ric distribution, with an increased density on 
the side of the cell closest to the wound, but 
were excluded from the lamellipodium at the 
leading edge. Such non-overlapping distribu-
tion of HDAC6 and acetylated MTs at the cell 
border is consistent with a role for HDAC6-
mediated deacetylation in motility and with 
active tubulin deacetylation taking place at 
the leading edge.
Slide 14: HDAC6 and GRK2 coimmuno-
precipitate and are able to interact directly
A functional interaction between GRK2 and 
HDAC6 is further backed by the following 
observations: First, GRK2 coimmunopre-
cipitates with hemagglutinin (HA)–tagged 
HDAC6 in cells transiently transfected with 
constructs encoding these proteins (A). 
Secondly, coimmunoprecipitation of endog-
enous HDAC6 and GRK2 can also be de-
tected in cytoplasmatic extracts from HeLa 
cells (B), indicating a specific association 
of these proteins under steady-state physio-
logical conditions. Last, the GRK2-HDAC6 
association does not require other protein 
intermediates, as indicated by the direct 
binding of recombinant GRK2 and gluta-
thione S-transferase (GST)–tagged HDAC6 
(C). Overall, our data support the notion 
that GRK2 directly interacts with HDAC6 
at the cell periphery to positively regulate 
its activity to promote local tubulin deacety-
lation, which would contribute to a gradient 
of MT instability that seems to be critical 
for migration (20, 21). The next question 
was how GRK2 stimulated HDAC6 activity.
Slide 15: GRK2 phosphorylates HDAC6 
to stimulate tubulin deactetylase activity
In vitro kinase assays revealed that purified 
GST-HDAC6 was readily phosphorylated 
by recombinant GRK2 with high affinity 
(left). Notably, in vitro deacetylation assays 
showed that preincubation with GRK2 un-
der phosphorylation-permissive conditions 
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clearly enhanced both the extent and kinet-
ics of HDAC6-mediated α-tubulin deacety-
lation (right), indicating that GRK2-medi-
ated phosphorylation was the mechanism 
underlying its direct positive modulatory 
effect on HDAC6 activity.
Slide 16: HDAC6 mutants with impaired 
phosphorylation by GRK2 fail to mimic the 
enhanced chemotactic motility promoted by 
WT HDAC6 in HeLa cells
We set out to identify the site (or sites) 
of HDAC6 phosphorylation by GRK2. 
In vitro and cellular assays (14) revealed 
serines 1060, 1062, and 1069 of HDAC6 
as important phosphoacceptor sites and in-
dicated that phosphorylation of HDAC6 at 
these residues was necessary for full tubu-
lin deacetylase activity. Moreover, mutant 
HDAC6 proteins in which either of two of 
these serine residues had been mutated to 
alanines (S1060A and S1062A) showed 
impaired phosphorylation by GRK2, and as 
shown in this slide, HeLa cells expressing 
constructs encoding these mutant HDAC6s 
failed to mimic the enhanced chemotactic 
motility promoted by WT HDAC6, which 
is similar to the effect of a tubulin-deacet-
ylase inactive mutant (HDAC6-DD). These 
data strongly suggest that HDAC6 phos-
phorylation by GRK2 plays an important 
role in the positive modulation of cell mo-
tility by these proteins.
Slide 17: GRK2-dependent regulation of 
HDAC6 activity modulates cell spreading 
kinetics
We have also investigated the potential in-
volvement of GRK2-mediated HDAC6 
modulation in cell spreading, which is also 
affected by changes in MT dynamics and 
acetylation (22, 23). To summarize our 
published data (14), we found that down-
regulation of GRK2 or expression of either 
GRK2S670A or GRK2K220R notably altered the 
normal spreading pattern of HeLa cells on 
FN-coated surfaces. These cells displayed 
an enhanced initial spreading, with earlier 
expansion of the MT network and a higher 
proportion of acetylated MTs as compared 
with WT cells, suggesting that modulation 
of HDAC6-mediated MT acetylation by 
GRK2 regulates the adhesion-independent 
early phase of cell spreading. However, un-
like cells lacking tubulin deacetylase activi-
ty, GRK2S670A- or GRK2K220R-expressing cells 
did not attain a larger final cellular area than 
that of WT cells, suggesting the involvement 
of GRK2 in additional, non-HDAC6–related 
processes during the late adhesion-depen-
dent phase of spreading (14).
Interestingly, many MTs were found in 
membrane protrusions at the cell periphery 
during the cell spreading, which is similar 
to the dynamic pioneer MTs observed at 
the lamellipodium of motile cells. These 
MTs were less acetylated at their distal than 
at their proximal ends (magnified images) 
during both early and late spreading of pa-
rental HeLa and cells overexpressing WT 
GRK2 (wt5 cells), but only during early 
spreading in HeLa-A1 and HeLa-K1 cells. 
Therefore, active tubulin deacetylation 
seems to be taking place at the cell edge 
late in spreading, in a process that requires 
GRK2 to be catalytically competent toward 
HDAC6 for the cell to spread fully. In sum-
mary, GRK2-HDAC6–mediated control of 
tubulin acetylation plays different modula-
tory roles during distinct phases of the cell 
spreading process.
Slide 18: Regulation of HDAC6 activity 
by GRK2 is dependent on GRK2 phosphor-
ylation status at Ser670
It is important to stress that the modula-
tory effect of GRK2 on HDAC6 can be 
dynamically regulated by the phosphoryla-
tion status of GRK2 at serine 670 (S670). 
As described in previous slides, tubulin 
acetylation was augmented in cells pro-
ducing either the catalytically inactive 
GRK2K220R protein or GRK2S670A, a mutant 
that retains catalytic activity toward GPCRs 
and tubulin. The inability of these mutants 
to modulate HDAC6 was not due to defec-
tive binding to HDAC6 (14). Remarkably, 
we observed that GRK2S670A showed a no-
ticeably reduced ability to phosphorylate 
HDAC6 as compared with WT GRK2 but 
did not show any defects in phosphorylating 
other GRK2 canonical substrates (top left). 
Interestingly, phosphorylation of GRK2 at 
S670 rapidly increases in response to pro-
migratory stimuli coincident with tubulin 
deacetylation (top right) and specifically 
increases where it colocalizes with HDAC6 
in pseudopodia of motile cells (bottom con-
focal images). These observations suggest 
that phosphorylation of GRK2 at S670 in 
the cell leading edge would facilitate local-
ized phosphorylation of HDAC6 in situ.
Slide 19: GRK2 phosphorylation at the 
S670 regulatory site acts as a switch that 
specifically modulates its ability to phos-
phorylate HDAC6
Overall, our results indicate that phosphory-
lation of GRK2 at the S670 regulatory site 
acts as a key switch that specifically modu-
lates its ability to phosphorylate HDAC6, 
thus affecting HDAC6 activity. The inabil-
ity of GRK2S670A to phosphorylate HDAC6, 
but not other substrates, constitutes the first 
example that phosphorylation at S670 could 
switch GRK2’s substrate repertoire. We 
propose that dynamic GRK2 phosphoryla-
tion at the leading edge induced by different 
pro-migratory stimuli would translate into 
dynamic, local HDAC6-mediated deacety-
lation of tubulin at the plus-ends of MTs, 
thus helping to maintain the cortical polar-
ization that underlies pseudopodia exten-
sion and directed migration.
As depicted in the lower schematic mod-
el, we postulate that upon chemotactic re-
ceptor activation, GRK2 would be recruited 
in a Gβγ-dependent manner to the lamellipo-
dium plasma membrane, where chemokine 
receptor stimulation would promote GRK2 
phosphorylation at S670 by MAPK. This in 
turn would switch on the ability of GRK2 
to phosphorylate colocalized HDAC6, re-
sulting in greater local deacetylase activity 
toward tubulin. The presence of highly dy-
namic, hypoacetylated MTs at the lamelli-
podium would stimulate cortical F-actin po-
lymerization and promote cell motility (14).
Slide 20: Dynamic modulation of GRK2 
networks by phosphorylation
Together with other recent results in our 
laboratory, our data further stress the notion 
that GRK2 phosphorylation by other kinas-
es could act as signaling switches to govern 
GRK2’s substrate specificity and its interac-
tions with cellular partners. For instance, 
phosphorylation of GRK2 at specific tyro-
sine residues by c-Src enhances its interac-
tion with the scaffold protein GIT1, whereas 
phosphorylation by MAPK at S670 shows 
the opposite effect (8). In the context of 
the cell cycle, Cdk2-mediated GRK2 phos-
phorylation at S670 promotes its interaction 
with the prolyl-isomerase Pin1, which is in-
strumental for the transient down-regulation 
of GRK2 abundance required for normal 
cell cycle progression (10). In this way, the 
phosphorylation status of GRK2 would be a 
key factor underlying the dynamic and stim-
uli-specific modulation of GRK2 networks.
Slide 21: Relevant GRK2 interactome 
in epithelial cell migration and physio-
pathological implications
In conclusion, we have identified a func-
tional interaction of GRK2 with HDAC6 
that plays an important role in cell spread-
ing and motility, thus adding another com-
ponent to the GRK2 interactome relevant 
to epithelial cell migration. We hypoth-
esize that this GRK2-HDAC6 relationship 
may have important implications in the 
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context of cancer cell migration and inva-
sion. HDAC6 activity and reduced tubulin 
acetylation have been associated with ma-
lignant transformation and invasive motility 
in breast cancer (18, 24). GRK2 abundance 
is up-regulated in several malignant mam-
mary cell lines compared with normal cells 
(12, 25), and increased GRK2 abundance 
enhances epithelial cell motility upon integ-
rin and GPCR engagement (8) and leads to 
reduced DNA damage–induced p53 respon-
siveness (10). Therefore, it is tempting to 
suggest that concurrent HDAC6 and GRK2 
up-regulation in human tumor malignancies 
would favor aberrant cell motility, adhesion, 
and transformation.
Slide 22: Acknowledgments
Most of the work regarding the functional 
interaction between HDAC6 and GRK2 
in epithelial cell migration was performed 
by postdoctoral fellow Vanesa Lafarga in 
our laboratory, with the leadership of my 
senior collaborator Petronila Penela, and 
involved collaboration with Olga Tapia of 
the Department of Anatomy and Cell Biol-
ogy, University of Cantabria–Spain. Other 
coauthors from my group have participated 
in additional lines of research that have un-
veiled more roles for GRK2 in cell signal-
ing in addition to its canonical role in GPCR 
desensitization. Our laboratory is funded 
by grants from Ministerio de Educación 
y Ciencia (SAF2011-23800), Fundación 
Ramón Areces, Instituto de Salud Carlos 
III (RD06-0014/0037 and PI11/00859), 
and Comunidad de Madrid (S2011/BMD-
2332).
Editor’s Note: This contribution is not in-
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